NCT01334944

Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

A Multi-Center, Open-Label, Surveillance Trial To Evaluate The Safety and Efficacy of a Shortened Infusion Time of Intravenous Ibuprofen.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: Cumberland Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.

Conditions

• Pain
• Fever

Interventions

Type	Name	Description
DRUG	Intravenous ibuprofen	400 mg or 800 mg intravenous ibuprofen administered intravenously over 5-10 minutes

Timeline

• Start date: 2011-06-01
• Primary completion: 2012-09-01
• Completion: 2012-10-01
• First posted: 2011-04-13
• Last updated: 2023-07-05
• Results posted: 2014-06-23

Locations

13 sites across 1 country: United States